Improved Glycemic Control With Surgical Tx of Obesity in Teens

Share this content:
Improved Glycemic Control With Surgical Tx of Obesity in Teens
Improved Glycemic Control With Surgical Tx of Obesity in Teens

WEDNESDAY, March 14, 2018 (HealthDay News) -- Surgical treatment of severe obesity in adolescents with type 2 diabetes is associated with better glycemic control and weight reduction than medical therapy, according to a study published online March 12 in JAMA Pediatrics.

Thomas H. Inge, M.D., Ph.D., from the University of Colorado Denver in Aurora, and colleagues compared glycemic control in cohorts of severely obese adolescents with type 2 diabetes undergoing medical and surgical interventions. Data were obtained for participants in the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS), who underwent a primary bariatric surgical procedure, and the Treatment Options of Type 2 Diabetes in Adolescents and Youth (TODAY) consortia, who were randomized to metformin alone or in combination with rosiglitazone or an intensive lifestyle intervention. Data from 30 Teen-LABS participants and 63 TODAY participants were analyzed.

The researchers found that the mean hemoglobin A1c concentration decreased from 6.8 to 5.5 percent in Teen-LABS and increased from 6.4 to 7.8 percent in TODAY participants during two years. In Teen-LABS there was a 29 percent decrease in body mass index compared with baseline, while a 3.7 percent increase was seen in TODAY. During two-year follow-up, 23 percent of Teen-LABS participants required a subsequent operation.

"These data support the need for a well-designed, prospective controlled study to define the role of surgery for adolescents with type 2 diabetes, including health and surgical outcomes," the authors write.

Several authors disclosed financial ties to the pharmaceutical and weight loss industries.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »